title: Target lesion failure with BRS? good old DES to the rescue.
abstract: Target lesion revascularization (TLR) for BRS failure is burdened with a high rate of adverse events. DES implantation appears to be the safest treatment option following BRS failure. A real world observational study with a minimum of 2-year follow-up would be required to investigate the long-term clinical outcomes in patients with a BRS failure and to assess the best treatment option in case of TLR.
authors.affiliation: The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.|Cardiothoracic Department, Division of Cardiology, University Hospital of Pisa, Italy.
authors.forename: Michela
authors.initials: M
authors.lastname: Faggioni
authors.affiliation: The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
mesh_terms: D017023:Coronary Angiography; D054855:Drug-Eluting Stents; D005500:Follow-Up Studies; D006801:Humans; D016896:Treatment Outcome